These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8591574)

  • 1. Do physicians estimate reliably the cardiovascular risk of hypertensive patients?
    Chatellier G; Blinowska A; Menard J; Degoulet P
    Medinfo; 1995; 8 Pt 2():876-9. PubMed ID: 8591574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Belgian global implementation of cardiovascular and stroke risk assessment study: methods and baseline data of the BELGICA-STROKE STUDY.
    Van der Niepen P; Thijs V; Devroey D; Fieuw A; Dramaix M; Van de Borne P
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):635-41. PubMed ID: 21450634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and preliminary testing of a patient decision aid to assist pharmaceutical care in the prevention of cardiovascular disease.
    Lalonde L; O'Connor AM; Drake E; Duguay P; Lowensteyn I; Grover SA
    Pharmacotherapy; 2004 Jul; 24(7):909-22. PubMed ID: 15303454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension].
    Hanon O; Franconi G; Mourad JJ; Baleydier A; Croce I; Girerd X
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):943-7. PubMed ID: 10989734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
    Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
    N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000.
    Imperatore G; Cadwell BL; Geiss L; Saadinne JB; Williams DE; Ford ES; Thompson TJ; Narayan KM; Gregg EW
    Am J Epidemiol; 2004 Sep; 160(6):531-9. PubMed ID: 15353413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the assessment of cardiovascular risk in selected general practices in Canterbury, New Zealand.
    Sheerin I; Hamilton G; Humphrey A; Scragg A
    N Z Med J; 2007 Sep; 120(1261):U2714. PubMed ID: 17853935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients.
    Fahey TP; Peters TJ
    Br J Gen Pract; 1996 Nov; 46(412):655-9. PubMed ID: 8978111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When should hypertension be treated? The different perspectives of Canadian family physicians and patients.
    McAlister FA; O'Connor AM; Wells G; Grover SA; Laupacis A
    CMAJ; 2000 Aug; 163(4):403-8. PubMed ID: 10976255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.